WebAug 1, 2024 · Structure Therapeutics is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat a wide range of chronic …
Did you know?
WebMar 22, 2024 · HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. MRKR, a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the... WebApr 12, 2024 · AUSTIN, Texas, April 12, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult to treat cancers, announced that the Company will report first quarter 2024 financial results on Thursday, April 20, 2024, …
WebApr 11, 2024 · Furthermore, Design Therapeutics’ net earnings loss ballooned from $35.5 million in 2024 to $63.3 million in 2024. In addition, the company’s cash, cash … WebLeap Therapeutics is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.
WebApr 3, 2024 · Financial Information Esperion Therapeutics, Inc. Financial Information SEC Filings Group Filing year - Any - Items per page 10 1 2 3 4 5 6 7 8 9 … Next › Last » Displaying 1 - 10 of 636 results Annual Reports 2024 Annual Report 2024 Annual Report Proxy Statements 2024 Special Meeting of Stockholders Proxy Statement 2024 Proxy … WebMar 23, 2024 · Regulus Therapeutics Inc. Selected Financial Information. Condensed Statement of Operations (In thousands, except share and per share data) Three months ended. December 31, Year ended. December 31 ...
WebMay 9, 2024 · Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2024 and Highlights Recent Corporate Updates News provided by Heron Therapeutics, Inc. May 09, 2024, 16:05...
WebApr 11, 2024 · Design Therapeutics Is in Poor Financial Health. Even if one or more of Design Therapeutics’ treatments is fully accepted by regulators, this doesn’t necessarily mean the company will succeed ... how to make pls donate text colorfulWeb19 hours ago · SAN FRANCISCO, April 13, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today reported financial results for the first quarter ended February 28, … mtg kiora master of depthsWebApr 12, 2024 · BETHESDA, Md., April 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology … mtg kozilek butcher of truthWebMar 23, 2024 · For the year ended December 31, 2024, Cognition Therapeutics reported a net loss of $21.4 million, or $0.91 per basic and diluted share, compared to a net loss of $11.7 million, or $3.13 per basic and diluted share for 2024. Conference Call Information how to make plow handlesWeb2 days ago · Most recently he was Chief Financial Officer of OncXerna Therapeutics, Inc., where he helped raise $30 million in an equity financing round. Prior to OncXerna, Mr. … mtg kresh the bloodbraided edhWeb3 hours ago · DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its first-quarter 2024 financial results on Wednesday, May 3, 2024, prior to the open of the U.S. financial markets.With the pending acquisition by Amgen Inc. and applicable securities laws, Horizon will not be hosting a conference call … how to make pls donate game in roblox studioWebSep 2, 2024 · What we do. The FTA exists to unite professionals from multiple disciplinary backgrounds to: foster the financial therapy profession. disseminate cutting edge research, best practices, and training that … how to make pls donate in roblox studio